BioSpring.Ltd – Healing Beyond Borders
  • Home
  • About Us
  • Our Focus
    • Press Release
    • Global Market
    • Product Pipeline
  • Manufacturing
  • Product Verify
  • Contact Us
  • Home
  • About Us
  • Our Focus
    • Press Release
    • Global Market
    • Product Pipeline
  • Manufacturing
  • Product Verify
  • Contact Us
Our Focus
  • All Categories
  • Our Focus
    • Product Pipeline
    • Global Market
    • Press Release
Tag
  • All Tags
  • PRnews
  • Generic Drug
Order By
  • Default
  • Order By Date
  • Order By Title
  • Order By ID
  • BioSpring Launches Generic Molnupiravir&(Nirmatrelvir/Ritonavir) to treat Covid-19 infection for Global Market Clients

    BioSpring Launches Generic Molnupiravir&(Nirmatrelvir/Ritonavir) to treat Covid-19 infection for Global Market Clients

    Global Market 01.11.2023 80 Views

    January 10, 2023, Vientiane, Laos--BioSpring ("BioSpring Group.LTD" "BioSpring Group") is launching Generic (Molnupiravir 200mg) capsules & Generic 150mg Nirmatrelvir/ 100mg Ritonavir tablets KIT for the treatment of Covid-19 virus infection. Molnupiravir is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID-19 in those infected by SARS-CoV-2. It is taken by mouth.The Generic…

  • BioSpring launches new product packaging for SaiLin’s global market customers

    BioSpring launches new product packaging for SaiLin’s global market customers

    Global Market 09.14.2022 302 Views

    September 14, 2022, Vientiane, Laos--BioSpring ("BioSpring Group.LTD" "BioSpring Group") launches New Product Packaging for SaiLin's Global Market Customers. This product packaging upgrade is to fulfill the previous promise of BioSpring's acquisition of SaiLin, and will continue to provide follow-up support and services to Sailin's global customers. The batch will use Biospring's anti-counterfeiting verification system. Including the following 7 anticancer drug…

  • BioSpring launches new drug Tadazen for customers in global market

    BioSpring launches new drug Tadazen for customers in global market

    Global Market 09.08.2022 216 Views

    September 08, 2022, Vientiane, Laos--BioSpring ("BioSpring Group.LTD" "BioSpring Group") is launching Tadazen (tadalafil) tablet for customers, which will be available in a single strength of 20mg, and each box of tadazen includes 8 tablets.It is a tablet taken by mouth. Onset is typically within half an hour and the duration is up to 36 hours. This product is manufactured and produced by…

  • BioSpring Announces Commercial Packaging Solutions for Formulation manufacturing

    BioSpring Announces Commercial Packaging Solutions for Formulation manufacturing

    Global Market 09.07.2022 292 Views

    September 07, 2022, Vientiane, Laos--BioSpring ("BioSpring Group.LTD" "BioSpring Group") announces coommerical packaging solutions for formulation manufacturing. Completing the prefabrication process for this commercial package ahead of time will help shorten the overall manufacturing cycle. Samuel, founder and CEO of BioSpring, said: “BioSpring can help customers overcome the challenges of formulating, processing and scaling up manufacturing of generic drugs.” Days it takes…

BioSpring.Ltd – Healing Beyond Borders

Our world-class finished dose manufacturing facility is located in the middle of the best industrial development areas in Laos [Saysetteha Development Zone]. The factory has specialized manufacturing modules for oral solid dose tablets, capsules, injections and caters to both export and domestic markets.

  • Our Focus
    • Press Release
    • Global Market
    • Product Pipeline
  • About Us
    • Manufacturing
    • Product Verify
    • Contact Us

Follow Us

  • LienTeh
  • Eeinpresswire

Copyright © 2022. BioSpring.LTD. All rights reserved.

Privacy Policy Terms & Conditions